Advice
in the absence of a submission from the holder of the marketing authorisation:
pitolisant (Wakix®) is not recommended for use within NHS Scotland.
Indication under review: Treatment of narcolepsy with or without cataplexy in adults
The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication. As a result we cannot recommend its use within NHSScotland.
Download detailed advice57KB (PDF)
Medicine details
- Medicine name:
- pitolisant (Wakix)
- SMC ID:
- 1229/17
- Indication:
- for the treatment of narcolepsy with or without cataplexy in adults.
- Pharmaceutical company
- Lincoln Medical Limited
- BNF chapter
- Central nervous system
- Submission type
- Non submission
- Status
- Not recommended
- Date advice published
- 13 February 2017